Who
Christian Elze
Director
Company insider
Files Form 4 as: Director, Protalix BioTherapeutics, Inc. (DE).
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 3 Sep 2025
- Last trade
- 3 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Sep 2026filed 4 Sep 2026 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 3 Sep 2026filed 4 Sep 2026 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —8,500 at $0.00 | filing |
| 3 Sep 2026filed 4 Sep 2026 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 3 Sep 2026filed 4 Sep 2026 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —8,500 at $0.00 | filing |
| 3 Sep 2025filed 4 Sep 2025 | PLX Protalix BioTherapeutics, Inc. (DE)option or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 3 Sep 2025filed 4 Sep 2025 | PLX Protalix BioTherapeutics, Inc. (DE)Biotechnology | SEC FORM 4 Code A | —7,500 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.